Why does ageing affect every system in the body — brain, joints, immune response, metabolism — at once? Researchers increasingly point to a common upstream driver: chronic oxidative stress and the low-grade inflammation it triggers. A 2023 mechanistic review in Antioxidants brought together what we currently know about how molecular hydrogen (H2) intervenes in that biology.
What the review examined
The authors — Rahman and colleagues from Yonsei University and Korea University College of Medicine — synthesised mechanistic, preclinical, and clinical evidence on H2 across several age-related conditions: Alzheimer’s disease, Parkinson’s disease, cancer, osteoporosis, metabolic syndrome, and cardiovascular disease. Their framing question: through which redox mechanisms does a molecule as small as H2 produce such broad effects on the biology of ageing?
Selective antioxidant action
Unlike many antioxidants that neutralise reactive oxygen species indiscriminately, H2 acts selectively on the most cytotoxic radicals — primarily the hydroxyl radical and peroxynitrite — while leaving physiologically useful signalling species intact. This selectivity is one reason H2‘s effects appear in disease models without disrupting normal cell function.
Anti-inflammatory and gene-regulatory effects
Beyond direct radical scavenging, the review highlights H2‘s ability to dampen pro-inflammatory signalling (NF-κB, TNF-α, IL-6) and to modulate gene expression linked to antioxidant defence systems such as the Nrf2 pathway. These pathways sit upstream of the chronic inflammation that drives most age-related disease.
Effects on the gut and endogenous hydrogen production
The review notes a less-obvious mechanism: H2 may favour the growth of beneficial gut bacteria that themselves produce endogenous intestinal hydrogen, creating a self-reinforcing reservoir of antioxidant capacity. This connects molecular hydrogen research to the broader field of microbiome-mediated health.
What it means in practice
This is a mechanistic review, not a single clinical trial — it does not establish dosing or outcomes for any individual condition. What it does provide is a coherent biological account of why molecular hydrogen continues to attract research attention across so many different age-related diseases. The practical takeaway is that the case for H2 rests less on a single dramatic effect and more on a quiet, selective modulation of the redox and inflammatory background against which ageing unfolds.
Citation: Rahman, M.H., Jeong, E.-S., You, H.S., Kim, C.-S., & Lee, K.-J. (2023). Redox-Mechanisms of Molecular Hydrogen Promote Healthful Longevity. Antioxidants, 12(5), 988. PubMed
